Skip to main content
. 2021 Oct 28;17(1):e202100576. doi: 10.1002/cmdc.202100576

Figure 23.

Figure 23

Structures from WO 2020/030143. (a) general scaffold; (b–f) most potent exemplified MERS‐CoV 3CLpro inhibitors.